Search research articles
Contact Us
Filters
Showing results (71-80 of 82) with videos related to
Page
of 9
Sort By:
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research
|
August 28, 2024
Development and Validation of Electronic Health Record Measures of Safety Planning Practices as Part of Zero Suicide Implementation
Jennifer M Boggs, Bobbi Jo H Yarborough, Gregory Clarke, et al.
Journal of Medicinal Chemistry
|
January 27, 2007
Alkynylpyrimidine amide derivatives as potent, selective, and orally active inhibitors of Tie-2 kinase
Victor J Cee, Brian K Albrecht, Stephanie Geuns-Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma
Eric D Hsi, Roxanne Steinle, Balaji Balasa, et al.
Frontiers in Pharmacology
|
March 7, 2019
Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways
Kent Miner, Katja Labitzke, Benxian Liu, et al.
Journal of the American Heart Association
|
March 28, 2018
Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network
Robert T Greenlee, Alan S Go, Pamela N Peterson, et al.
Journal of Medicinal Chemistry
|
February 19, 2008
Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity
Matthew W Martin, John Newcomb, Joseph J Nunes, et al.
Journal of Medicinal Chemistry
|
June 11, 2016
Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors
Liping H Pettus, Kristin L Andrews, Shon K Booker, et al.
Journal of Medicinal Chemistry
|
January 10, 2019
Discovery of ( R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4- b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3 H)-one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological Malignancies
Hui-Ling Wang, Kristin L Andrews, Shon K Booker, et al.
Faraday Discussions
|
July 24, 2023
Make - underpinning concepts of the synthesis of systems where non-covalent interactions are important: general discussion
Torsten Beweries, Michael R Buchmeiser, Frances E Bugden, et al.
Journal of Medicinal Chemistry
|
March 7, 2008
Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation
Erin F DiMauro, John Newcomb, Joseph J Nunes, et al.
Page
of 9
Search research articles
Search
Showing results (71-80 of 82) with videos related to
Sort By:
Page
of 9
Archives of Suicide Research : Official Journal of the International Academy for Suicide Research
|
August 28, 2024
Development and Validation of Electronic Health Record Measures of Safety Planning Practices as Part of Zero Suicide Implementation
Jennifer M Boggs, Bobbi Jo H Yarborough, Gregory Clarke, et al.
Journal of Medicinal Chemistry
|
January 27, 2007
Alkynylpyrimidine amide derivatives as potent, selective, and orally active inhibitors of Tie-2 kinase
Victor J Cee, Brian K Albrecht, Stephanie Geuns-Meyer, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 3, 2008
CS1, a potential new therapeutic antibody target for the treatment of multiple myeloma
Eric D Hsi, Roxanne Steinle, Balaji Balasa, et al.
Frontiers in Pharmacology
|
March 7, 2019
Drug Repurposing: The Anthelmintics Niclosamide and Nitazoxanide Are Potent TMEM16A Antagonists That Fully Bronchodilate Airways
Kent Miner, Katja Labitzke, Benxian Liu, et al.
Journal of the American Heart Association
|
March 28, 2018
Device Therapies Among Patients Receiving Primary Prevention Implantable Cardioverter-Defibrillators in the Cardiovascular Research Network
Robert T Greenlee, Alan S Go, Pamela N Peterson, et al.
Journal of Medicinal Chemistry
|
February 19, 2008
Structure-based design of novel 2-amino-6-phenyl-pyrimido[5',4':5,6]pyrimido[1,2-a]benzimidazol-5(6H)-ones as potent and orally active inhibitors of lymphocyte specific kinase (Lck): synthesis, SAR, and in vivo anti-inflammatory activity
Matthew W Martin, John Newcomb, Joseph J Nunes, et al.
Journal of Medicinal Chemistry
|
June 11, 2016
Discovery and Optimization of Quinazolinone-pyrrolopyrrolones as Potent and Orally Bioavailable Pan-Pim Kinase Inhibitors
Liping H Pettus, Kristin L Andrews, Shon K Booker, et al.
Journal of Medicinal Chemistry
|
January 10, 2019
Discovery of ( R)-8-(6-Methyl-4-oxo-1,4,5,6-tetrahydropyrrolo[3,4- b]pyrrol-2-yl)-3-(1-methylcyclopropyl)-2-((1-methylcyclopropyl)amino)quinazolin-4(3 H)-one, a Potent and Selective Pim-1/2 Kinase Inhibitor for Hematological Malignancies
Hui-Ling Wang, Kristin L Andrews, Shon K Booker, et al.
Faraday Discussions
|
July 24, 2023
Make - underpinning concepts of the synthesis of systems where non-covalent interactions are important: general discussion
Torsten Beweries, Michael R Buchmeiser, Frances E Bugden, et al.
Journal of Medicinal Chemistry
|
March 7, 2008
Structure-guided design of aminopyrimidine amides as potent, selective inhibitors of lymphocyte specific kinase: synthesis, structure-activity relationships, and inhibition of in vivo T cell activation
Erin F DiMauro, John Newcomb, Joseph J Nunes, et al.
Page
of 9